Morgan Stanley
RVNC

Morgan Stanley’s Revance Therapeutics, Inc. RVNC Stock Holding History

Quarter Market Value Status Shares Shares
Change %
Trade Value Portfolio Weight Portfolio Position
2025
Q1
Sell
-893,686
Closed -$2.72M 8306
2024
Q4
$2.72M Buy
893,686
+26,559
+3% +$80.7K ﹤0.01% 4474
2024
Q3
$4.5M Sell
867,127
-109,968
-11% -$571K ﹤0.01% 4037
2024
Q2
$2.51M Sell
977,095
-226,809
-19% -$583K ﹤0.01% 4406
2024
Q1
$5.92M Sell
1,203,904
-554,594
-32% -$2.73M ﹤0.01% 3786
2023
Q4
$15.5M Buy
1,758,498
+1,156,303
+192% +$10.2M ﹤0.01% 3567
2023
Q3
$6.91M Sell
602,195
-37,561
-6% -$431K ﹤0.01% 3465
2023
Q2
$16.2M Sell
639,756
-94,220
-13% -$2.38M ﹤0.01% 2689
2023
Q1
$23.6M Sell
733,976
-64,820
-8% -$2.09M ﹤0.01% 2239
2022
Q4
$14.7M Buy
798,796
+116,091
+17% +$2.14M ﹤0.01% 2653
2022
Q3
$18.4M Buy
682,705
+179,621
+36% +$4.85M ﹤0.01% 2276
2022
Q2
$6.95M Buy
503,084
+85,977
+21% +$1.19M ﹤0.01% 3455
2022
Q1
$8.13M Buy
417,107
+48,020
+13% +$936K ﹤0.01% 3151
2021
Q4
$6.02M Buy
369,087
+86,477
+31% +$1.41M ﹤0.01% 3518
2021
Q3
$7.87M Sell
282,610
-8,114
-3% -$226K ﹤0.01% 3184
2021
Q2
$8.62M Buy
290,724
+122,144
+72% +$3.62M ﹤0.01% 3157
2021
Q1
$4.71M Buy
168,580
+16,616
+11% +$464K ﹤0.01% 3483
2020
Q4
$4.31M Buy
151,964
+63,121
+71% +$1.79M ﹤0.01% 3417
2020
Q3
$2.23M Sell
88,843
-10,371
-10% -$261K ﹤0.01% 3558
2020
Q2
$2.42M Buy
99,214
+67,557
+213% +$1.65M ﹤0.01% 3413
2020
Q1
$468K Sell
31,657
-58,231
-65% -$861K ﹤0.01% 4415
2019
Q4
$1.46M Buy
89,888
+62,049
+223% +$1.01M ﹤0.01% 4270
2019
Q3
$362K Buy
27,839
+21,771
+359% +$283K ﹤0.01% 4834
2019
Q2
$79K Sell
6,068
-102,148
-94% -$1.33M ﹤0.01% 5429
2019
Q1
$1.71M Sell
108,216
-45,030
-29% -$710K ﹤0.01% 3715
2018
Q4
$3.08M Sell
153,246
-294
-0.2% -$5.92K ﹤0.01% 3408
2018
Q3
$3.82M Sell
153,540
-29,219
-16% -$726K ﹤0.01% 3470
2018
Q2
$5.02M Buy
182,759
+12,358
+7% +$339K ﹤0.01% 3145
2018
Q1
$5.25M Sell
170,401
-57,607
-25% -$1.77M ﹤0.01% 2982
2017
Q4
$8.15M Buy
228,008
+101,236
+80% +$3.62M ﹤0.01% 2606
2017
Q3
$3.49M Sell
126,772
-52,319
-29% -$1.44M ﹤0.01% 3339
2017
Q2
$4.73M Buy
179,091
+25,421
+17% +$671K ﹤0.01% 2906
2017
Q1
$3.2M Sell
153,670
-27,626
-15% -$575K ﹤0.01% 3368
2016
Q4
$3.75M Buy
181,296
+65,031
+56% +$1.35M ﹤0.01% 3298
2016
Q3
$1.88M Buy
116,265
+26,228
+29% +$425K ﹤0.01% 3543
2016
Q2
$1.23M Buy
90,037
+14,841
+20% +$202K ﹤0.01% 3823
2016
Q1
$1.31M Buy
75,196
+54,397
+262% +$949K ﹤0.01% 3701
2015
Q4
$711K Buy
20,799
+17,239
+484% +$589K ﹤0.01% 4297
2015
Q3
$106K Sell
3,560
-55,860
-94% -$1.66M ﹤0.01% 5395
2015
Q2
$1.9M Buy
59,420
+52,373
+743% +$1.67M ﹤0.01% 3679
2015
Q1
$146K Buy
7,047
+506
+8% +$10.5K ﹤0.01% 5361
2014
Q4
$111K Buy
6,541
+635
+11% +$10.8K ﹤0.01% 5503
2014
Q3
$115K Buy
5,906
+1,393
+31% +$27.1K ﹤0.01% 5420
2014
Q2
$154K Sell
4,513
-58,307
-93% -$1.99M ﹤0.01% 5286
2014
Q1
$1.98M Buy
+62,820
New +$1.98M ﹤0.01% 3428